CSIMarket
 
Charge Enterprises Inc   (CRGE)
Other Ticker:  
 
    Sector  Services    Industry Communications Services
   Industry Communications Services
   Sector  Services
 
Price: $1.0900 $-0.02 -1.357%
Day's High: $1.16 Week Perf: -7.63 %
Day's Low: $ 1.07 30 Day Perf: -7.63 %
Volume (M): 269 52 Wk High: $ 6.12
Volume (M$): $ 293 52 Wk Avg: $2.44
Open: $1.14 52 Wk Low: $1.05



 Market Capitalization (Millions $) 95
 Shares Outstanding (Millions) 87
 Employees -
 Revenues (TTM) (Millions $) 698
 Net Income (TTM) (Millions $) -29
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 0

Charge Enterprises Inc


   Company Address: 125 Park Avenue New York 10017 NY
   Company Phone Number: 921-2100   Stock Exchange / Ticker: NASDAQ CRGE
   CRGE is expected to report next financial results on May 15, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Vor Biopharma Inc

The company reported operating loss of $-24.725 millions, in the fourth quarter of 2022 financial report

Following the bellwethers in the Biotechnology & Pharmaceuticals industry, a number of overlooked businesses are coming in with the earnings. VOR revealed it has realized operating loss of $-24.725 millions, for the fourth quarter of 2022.

One Stop Systems Inc

Shortfall Despite of Sales improvement at the company all along the most recent fiscal period

For the most recent fiscal period One Stop Systems Inc increased a deficit per share of $-0.16 per share compare to $-0.02 a year ago and Income per Share fell from $0.01 per share from the prior financial reporting period.

Sales grew slightly by 2.658 % to $18.25 millions from $17.78 millions in the corresponding financial reporting period a year ago and sequentially Sales decreased by -3.01 % from $18.82 millions.

Cyteir Therapeutics Inc

Directing the awareness towards the fiscal period ending December 31 2022 the Major Pharmaceutical Preparations company decreased a loss per share at $-0.25 per share, relative to the earnings of $-33.63 per share a year ago financial reporting period, In the preceding financial reporting period the Cyteir Therapeutics Inc realized $-0.31 per share.

Finch Therapeutics Group Inc

Extremely challenging reporting period for Finch Therapeutics Group Inc in the financial fourth quarter of 2022

Finch Therapeutics Group Inc disclosed disastrous most recent fiscal period, where Sales faded by -99.007 % to $0.01 millions and net loss per share has swelled to $-0.56, from the similar reporting period a year ago.

Ars Pharmaceuticals Inc

The Major Pharmaceutical Preparations company announced Sales of $1.316 millions, in the Dec 31 2022 report

SPRY proclaimed $1.316 millions, in Sales in the financial span closing December 31 2022.






 

Charge Enterprises Inc 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UHS's Profile

Stock Price

UHS's Financials

Business Description

Fundamentals

Charts & Quotes

UHS's News

Suppliers

UHS's Competitors

Customers & Markets

Economic Indicators

UHS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071